Pharma Journalist -

Division of Valeant Pharmaceuticals International, Inc., Ortho Dermatologics asserted that the U.S Food and Drug Administration accepted the New Drug Application for JEMDEL  …
Read More...

PharmaMar forays into an exclusive licensing agreement with Seattle Genetics ensuring access to certain PharmaMar proprietary molecules for the development and commercialization of…
Read More...

Amgen asserted that the Oncologic Drugs Advisory Committee of the U.S Food and Drug Administration will assess the data supporting the BLINCYTO supplemental Biologics License…
Read More...

Philadelphia, PA (Feb 14) IQPC’s Pharma Anti-Counterfeiting & Brand Protection Summit, the nation’s foremost event addressing innovative solutions to manage and create your brand…
Read More...

In the run up to the 3rd annual Pre-Filled Syringes West Coast Conference (4 – 5 June, San Diego, US), SMi Group caught up with Paul Upham, Senior Principal, Genentech to discuss common…
Read More...

Ace RNA medicines company, Arcturus Therapeutics asserted the appointment of Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and…
Read More...

Charles River Laboratories International declared that it has ventured into a definitive agreement to obtain MPI Research for $800 million in cash. James C. Foster, Chairman and…
Read More...

Leading provider of nonclinical contract research services and research models, Envigo asserted the appointment of Lynn Lewis to the position of  Senior Vice President, Global Sales.…
Read More...

U.S Food and Drug Administration paved way for the marketing of the Viz.AI Contact application which is a type of clinical decision support software designed to interpret computed…
Read More...

Leading clinical trial technology and specialty services provider, Bracket declared the appointment of Michael Nolte as the company's Chief Executive Officer. Michael Nolte served as…
Read More...